September 30, 2014
Boston, MA
There have been a plethora of decisions addressing complex patent issues in the pharmaceutical and biotech space at all levels of the judicial system, forcing companies and the USPTO to rapidly adjust. This program will address recent case law and delve into how those decisions are impacting the parties’ efforts to settle ANDA litigations and properly draft claims to encompass patentable subject matter. Topics to be discussed include:
Speakers:
Howard W. Levine
Alissa K. Lipton
Leslie A. McDonell
Sanya Sukduang
Date:
Tuesday, September 30, 2014
Time:
9:15 - 9:45 a.m. – Registration and Breakfast
9:45 a.m. - 12:00 p.m. – Workshop
12:00 - 12:30 p.m. – Working Lunch
12:30 - 3:00 p.m. – Workshop
Location:
Finnegan
Two Seaport Lane
Boston, MA 02210
Hybrid Conference
Intellectual Property Law Institute 2026 – California
October 19-20, 2026
San Francisco
Hybrid Conference
Intellectual Property Law Institute 2026 – New York
September 28-29, 2026
New York
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.